Review article
Antibodies to lipopolysaccharide

https://doi.org/10.1016/0022-1759(95)00123-RGet rights and content

Abstract

Lipopolysaccharides (LPS) are indispensable structural components of the Gram-negative bacterial outer membrane and are major determinants of virulence in pathogenic species. In the infected host LPS is better known as endotoxin where it acts as a potent stimulator of the inflammatory response. This article reviews the methods for the production and measurement of anti-LPS antibodies, and then describes the uses to which these methods have been employed. Antibodies to LPS (either monoclonal or polyclonal) may be used directly as immunotherapeutic agents for the treatment of Gram-negative sepsis or endotoxaemia, or as probes for the diagnosis and epidemiological investigation of Gram-negative bacterial infections. Antibodies are useful tools for investigation of the chemical structure of LPS, its expression on bacteria and to study the role of LPS in pathogenic mechanisms. The detection and quantitation of anti-LPS antibodies has formed the basis of classical and more recent serological studies of major bacterial infections.

References (85)

  • B.J. Appelmelk et al.

    Antigenic and immunogenic differences in lipopolysaccharides of Escherichia coli J5 vaccine strains of different origins

    J. Gen. Microbiol.

    (1993)
  • M.K. Aydintung et al.

    Cross-reactivity of monoclonal antibodies to Escherichia coli J5 with heterologous gram negative bacteria and extracted lipopolysaccharides

    J. Infect. Dis.

    (1989)
  • G.R. Barclay

    Antibodies to endotoxin in health and disease

    Rev. Med. Microbiol.

    (1990)
  • G.R. Barclay et al.

    Serological relationships between Escherichia coli and Salmonella smooth-and rough-mutant lipoplysaccharides as revealed by enzyme-linked immunosorbent assay for human immunoglobulin G antiendotoxin antibodies

    Infect. Immun.

    (1987)
  • G.R. Barclay et al.

    Changes in anti-endotoxin IgG antibody and endotoxaemia in three cases of gram-negative septic shock

    Circ. Shock

    (1989)
  • J.D. Baumgartner

    Anti-endotoxin antibodies as treatment for sepsis — lessons to be learnt

    Rev. Med. Microbiol.

    (1994)
  • J.D. Baumgartner et al.

    Antibodies to lipopolysaccharides after immunization of humans with the rough mutant Escherichia coli J5

    J. Infect. Dis.

    (1991)
  • A.K. Bhattacharjee et al.

    Affinity-purified Escherichia coli J5 lipopolysaccharide-specific IgG protects neutropenic rats against gram-negative bacterial sepsis

    J. Infect. Dis.

    (1994)
  • R.C. Bone

    Gram-negative sepsis — a dilemma of modern medicine

    Clin. Microbiol. Rev.

    (1993)
  • L. Brade et al.

    Characterization of two different antibody specificities recognizing distinct antigenic determinants in free lipid A

    Infect. Immun.

    (1985)
  • H. Brade et al.

    Chemical and serological investigations on the genus-specific lipopolysaccharide epitope of Chlamydia

  • L. Brade et al.

    Use of synthetic antigens to determine the epitope specificities of monoclonal antibodies against the 3-deoxy-d-manno-octulosonate region of bacterial lipopolysaccharide

    Infect. Immun.

    (1987)
  • L. Brade et al.

    Characterization of murine monoclonal antibodies and murine, rabbit, and human polyclonal antibodies against chlamydial lipopolysaccharide

    Infect. Immun.

    (1990)
  • P. Brandtzaeg et al.

    Meningococcal endotoxin in lethal septic shock plasma studied by gas chromatography, mass spectrometry, ultracentrifugation and electron microscopy

    J. Clin. Invest.

    (1992)
  • R.S. Burd et al.

    Anti-endotoxin monoclonal antibodies inhibit secretion of tumor necrosis factor-alpha by 2 distinct mechanisms

    Ann. Surg.

    (1993)
  • H.E. Carlsson et al.

    Titration of antibodies to Salmonella O antigens by enzyme-linked immunosorbent assay

    Infect. Immun.

    (1972)
  • H. Chart et al.

    A rapid immunoblotting procedure for detecting serum antibodies to the lipopolysaccharide of Escherichia coli O157

    Lett. Appl. Microbiol.

    (1994)
  • D. Choi et al.

    Sandwich capture ELISA by a murine monoclonal antibody against a genus-specific LPS epitope for the detection of different common serotypes of salmonellas

    J. Appl. Bacteriol.

    (1992)
  • W.D.B. Clements et al.

    Effects of extrahepatic obstructive jaundice on Kupffer cell clearance capacity

    Arch. Surg.

    (1993)
  • D. Colwell-Ward et al.

    Monoclonal antibodies to Salmonella lipopolysaccharide: functional analysis of anti-lipid A antibodies

    Clin. Exp. Immunol.

    (1988)
  • S.J. Cryz et al.

    Safety and immunogenicity of a Pseudomonas aeruginosa O-polysaccharide-toxin A conjugate vaccine in humans

    J. Clin. Invest.

    (1987)
  • S.J. Cryz et al.

    Immunogenicity of Escherichia coli O18 O-specific polysaccharide (O-PS)-toxin A and O-PS-cholera toxin conjugate vaccines in humans

    J. Infect. Dis.

    (1991)
  • J. De Jongh-Leuvenink et al.

    Detection of antibodies against lipopolysaccharides of Escherichia coli and Salmonella R and S strains by immunoblotting

    Infect. Immun.

    (1985)
  • J. De Jongh-Leuvenink et al.

    Characterization of anti-core glycolipid monoclonal antibodies with chemically defined lipopolysaccharides

    Infect. Immun.

    (1990)
  • F.E. Di Padova et al.

    A broadly cross-protective monoclonal antibody binding to Escherichia coli and Salmonella lipopolysaccharides

    Infect. Immun.

    (1993)
  • F.E. Di Padova et al.

    Anti-lipopolysaccharide core antibodies

  • D.M. Edmond et al.

    The accessibility of cross-reactive anti-lipopolysaccharide-core monoclonal antibodies to Escherichia coli grown in sub-MICs of temocillin and other antibiotics

    J. Antimicrob. Chemother.

    (1993)
  • M.E. Evans et al.

    Fluorescence-activated cell sorter analysis of binding by lipopolysaccharide-specific monoclonal antibodies to Gram-negative bacteria

    J. Infect. Dis.

    (1990)
  • M.E. Evans et al.

    Lipopolysaccharide heterogeneity in Escherichia coli J5 variants — analysis by flow cytometry

    J. Infect. Dis.

    (1992)
  • A. Fomsgaard et al.

    Antibodies from chronically infected cystic fibrosis patients react with lipopolysaccharides extracted by new micromethods from all serotypes of Pseudomonas aeruginosa

    APMIS

    (1993)
  • A.P. Gibb et al.

    Urinary IgG antibody against mixed heat-killed coliform antigen and lipopolysaccharide core antigen

    J. Clin. Pathol.

    (1992)
  • A.P. Gibb et al.

    Frequencies of lipopolysaccharide core types among clinical isolates of Escherichia coli defined with monoclonal antibodies

    J. Infect. Dis.

    (1992)
  • Cited by (0)

    View full text